新型冠状病毒肺炎治疗药物的研究进展  

Currentstatus andadvances for development of drugs to treat coronavirus disease 2019

作　　者：赵承奇 靳增华 王雪芬(综述) 吴永新(审校)[1] ZHAO Cheng-qi;JIN Zeng-hua;WANG Xue-fen(reviewing);WU Yong-xin(checking)(Department of Respiratory,946 Hospital,PLA,Yining 835000,Xinjing,China)

机构地区：[1]中国人民解放军陆军第九四六医院呼吸科,伊宁835000

出　　处：《东南国防医药》2021年第1期58-63,共6页Military Medical Journal of Southeast China

摘　　要：2019年底由新型冠状病毒引发的疫情迅速蔓延,由于传染能力较强,按甲类传染病管理,并陆续发布了8版试行的《新型冠状病毒感染肺炎诊疗方案》,诊疗方案里提及了几种以往用于治疗其他病毒感染的抗病毒药物。文章主要就冠状病毒的结构与分类进行介绍,对其起源、流行病学以及治疗现状与进展进行汇总,对目前已用于临床和研发中预防和治疗冠状病毒的药物进行综述。In the end of December 2019,the epidemic caused by 2019-NCOV has spread rapidly.Due to the strong infectious capacity,and as A classic infectious disease management,and successively released 8 versions of the trial treatment scheme of novel coronavirus infectious pneumonia.Several antiviral drugs previously used to treat other viral infections are mentioned in the protocol.This paper introduces the structure and classification of coronavirus,discusses its origin and epidemiology,summarizes the treatment status and progress of a novel coronavirus,and introduces the drugs that have been used to treat coronavirus in the clinic and in research and development.

关 键 词：新型冠状病毒 新型冠状病毒肺炎 治疗药物 现状 进展 

分 类 号：R563.19[医药卫生—呼吸系统]